Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial
Study Approval Paves the Way for Trial Participants to Begin Taking Apabetalone
Donald Mccaffrey University Of Alberta Biomedical Panel Health Research Ethics Board World Health Organization Drug Administration
Source: leaderpost.com